SlideShare a Scribd company logo
09/08/16 1
Micro-array study for gene
expression
09/08/16 2
History
cDNA microarrays have evolved from Southern blots, withcDNA microarrays have evolved from Southern blots, with
clone libraries gridded out on nylon membrane filtersclone libraries gridded out on nylon membrane filters
being an important and still widely used intermediate.being an important and still widely used intermediate.
Things took off with the introduction of non-porous solidThings took off with the introduction of non-porous solid
supports, such as glass - these permitted miniaturization -supports, such as glass - these permitted miniaturization -
and fluorescence based detection. Currently, about 20,000and fluorescence based detection. Currently, about 20,000
cDNAs can be spotted onto a microscope slide.cDNAs can be spotted onto a microscope slide.
09/08/16 3
Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
THE PROCESSTHE PROCESS
Building the Chip:
MASSIVE PCR PCR PURIFICATION
and PREPARATION
PREPARING
SLIDES
PRINTING
Preparing RNA:
CELL CULTURE
AND HARVEST
RNA ISOLATION
cDNA PRODUCTION
Hybing the Chip:
POST PROCESSING
ARRAY HYBRIDIZATION
PROBE LABELING
DATA ANALYSIS
09/08/16 4Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
cDNA clones
(probes)
PCR product amplification
purification
printing
microarray Hybridise target
to microarray
mRNA target)
excitation
laser 1laser 2
emission
scanning
analysis
overlay images and normalise
0.1nl/spot
09/08/16 5Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Preparing RNA:
RNA ISOLATION
cDNA PRODUCTION
Designing experiments to profile conditions/perturbations/
mutations and carefully controlled growth conditions
RNA yield and purity are determined by system. PolyA isolation is preferable
but total RNA is useable. Two RNA samples are hybridized/chip.
Single strand synthesis or amplification of RNA can be performed.
cDNA production includes incorporation of Aminoallyl-dUTP.
Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Preparing RNA:
RNA ISOLATION
cDNA PRODUCTION
Designing experiments to profile conditions/perturbations/
mutations and carefully controlled growth conditions
RNA yield and purity are determined by system. PolyA isolation is preferable
but total RNA is useable. Two RNA samples are hybridized/chip.
Single strand synthesis or amplification of RNA can be performed.
cDNA production includes incorporation of Aminoallyl-dUTP.
Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Preparing RNA:
RNA ISOLATION
cDNA PRODUCTION
Designing experiments to obtain conditions necessary to
induce changes in the plaque to cause its rupture
RNA yield and purity are determined by system.
Single strand synthesis or amplification of RNA can be performed.
OBTAINING THE
TARGET TISSUE
09/08/16 6Department of Statistics, University of California, Berkeley, and
Hybing the Chip:
ARRAY HYBRIDIZATION
PROBE LABELING
DATA ANALYSIS
Cy3 and Cy5 RNA samples are simultaneously
hybridized to chip. Hybs are performed for 5-12 hours
and then chips are washed.
Two RNA samples are labelled with Cy3 or
Cy5 monofunctional dyes via a chemical
coupling to AA-dUTP. Samples are purified
using a PCR cleanup kit.
Ratio measurements are determined via
quantification of 532 nm and 635 nm
emission values. Data are uploaded to the
appropriate database where statistical and
other analyses can then be performed.
09/08/16 7Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
Biological
Question
Sample
preparationMicroarray
Life Cycle
Data Analysis
& Modeling
Microarray
Reaction
Microarray
Detection
aken from Schena & Davis
09/08/16 8
Schematic of probe preparation , hybridization,
scanning and immage analysis
09/08/16 9
09/08/16 10
Our Aim
• We intend to induce rupture of atherosclerotic plaque in
apo-e mice by injecting several drugs, which we hope will
cause rupture of the plaque by altering the hemodynamic
system and raising the oxidative stress and alter the
composition of the plaque.
• After achieving this goal we will perform gene- array
study on these specimens and will try to find out which
genes are expressed more in plaques which are ruptured or
are prone to rupture, by comparing our results at the
histopathology lab which will define the structural details
of such vulnerable plaques.
09/08/16 11
DNA Sequence Synthesis
 We are going to design a genearray slide based onWe are going to design a genearray slide based on
oligonucleotide sequences that we will deriveoligonucleotide sequences that we will derive
from the genes that we are interested in.from the genes that we are interested in.
 To do this, we will proceed as follows:To do this, we will proceed as follows:
 First we will gather the cDNA or mRNAFirst we will gather the cDNA or mRNA
sequences of the desired genes from Entrez.sequences of the desired genes from Entrez.
 Then we will pickup a sequence of genes from thatThen we will pickup a sequence of genes from that
particular gene and by using Primer Premierparticular gene and by using Primer Premier
program we will design a primer to use as aprogram we will design a primer to use as a
hybridization probe.hybridization probe.
09/08/16 12Department of Statistics, University of California, Berkeley, and
Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
09/08/16 13
09/08/16 14
09/08/16 15
 We will order a probe to be made by a company that willWe will order a probe to be made by a company that will
make that on a commercial basis.make that on a commercial basis.
 The micro array-chip, we will make at the lab byThe micro array-chip, we will make at the lab by
synthesizing cDNA from mRNA, that we isolated.synthesizing cDNA from mRNA, that we isolated.
 We will obtain the tissue samples from the mice, accordingWe will obtain the tissue samples from the mice, according
to our study design, we will purify the mRNA accordingto our study design, we will purify the mRNA according
the specific protocol.the specific protocol.
 mRNA from the target will be converted into cDNA, andmRNA from the target will be converted into cDNA, and
allowed to hybridiz on the microarray chip that weallowed to hybridiz on the microarray chip that we
designeddesigned
 The emission of colors will be captured by the scanner,The emission of colors will be captured by the scanner,
and the results will be analysed depending upon theirand the results will be analysed depending upon their
intensity and presence and absence of colorintensity and presence and absence of color
09/08/16 16
• Drugs being used to
induce rupture of
atherosclerotic plaque
in apo-e mice
09/08/16 17
Drugs being used
• LNAME
• Adrenalin
• Cocaine
• Xanthine
• Xanthine Oxidase
• Interleukin-1 beta
• Methionine
• Buthionine Sulfoximine
09/08/16 18
If we do not find
anything
Very pleasant, at least
we shalll find
something new

More Related Content

What's hot

Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ...
 Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ... Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ...
Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ...
Fabio Caligaris
 
Nervni sistem slike
Nervni sistem  slikeNervni sistem  slike
Nervni sistem slike
dr Šarac
 
I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad
TECNALIA Research & Innovation
 
060516_UMH_AC
060516_UMH_AC060516_UMH_AC
060516_UMH_AC
Alberto Carbonell
 
Gist Croft, "Self-organization of the in vitro attached human embryo and its ...
Gist Croft, "Self-organization of the in vitro attached human embryo and its ...Gist Croft, "Self-organization of the in vitro attached human embryo and its ...
Gist Croft, "Self-organization of the in vitro attached human embryo and its ...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...
George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...
George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
CRISPR/Cas9 Platform
CRISPR/Cas9 PlatformCRISPR/Cas9 Platform
CRISPR/Cas9 Platform
Stella Evelyn
 
C. trachoamtis detection and genotypings assay
C. trachoamtis detection and genotypings assayC. trachoamtis detection and genotypings assay
C. trachoamtis detection and genotypings assay
quint
 
Dipesh
DipeshDipesh
Avances en genética. Utilidad de la NGS y la bioinformática.
Avances en genética. Utilidad de la NGS y la bioinformática.Avances en genética. Utilidad de la NGS y la bioinformática.
Avances en genética. Utilidad de la NGS y la bioinformática.
BBK Innova Sarea
 
C dna and genomic libraries amirtham
C dna and genomic libraries   amirthamC dna and genomic libraries   amirtham
C dna and genomic libraries amirtham
christanantony
 
PAG-2004-Roe
PAG-2004-RoePAG-2004-Roe
PAG-2004-Roe
mounir elharam
 
Resume Jean Wei 111616
Resume Jean Wei 111616Resume Jean Wei 111616
Resume Jean Wei 111616
Jean Wei
 
Single cell.platforms.v1.1
Single cell.platforms.v1.1Single cell.platforms.v1.1
Single cell.platforms.v1.1
Albert Vilella
 
Long read sequencing - WEHI bioinformatics seminar - tue 16 june 2015
Long read sequencing -  WEHI  bioinformatics seminar - tue 16 june 2015Long read sequencing -  WEHI  bioinformatics seminar - tue 16 june 2015
Long read sequencing - WEHI bioinformatics seminar - tue 16 june 2015
Torsten Seemann
 
Molecular biology
Molecular biologyMolecular biology
Molecular biology
sarapuertacalderon
 
J. Clin. Microbiol.-2015-Liljander-2810-5
J. Clin. Microbiol.-2015-Liljander-2810-5J. Clin. Microbiol.-2015-Liljander-2810-5
J. Clin. Microbiol.-2015-Liljander-2810-5
Elizabeth O'Brien
 
Mackey Bio Perl Bosc2008
Mackey Bio Perl Bosc2008Mackey Bio Perl Bosc2008
Mackey Bio Perl Bosc2008
bosc_2008
 
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...
Roberto Scarafia
 

What's hot (19)

Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ...
 Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ... Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ...
Odyssey Of The IWGSC Reference Genome Sequence: 12 Years 1 Month 28 Days 11 ...
 
Nervni sistem slike
Nervni sistem  slikeNervni sistem  slike
Nervni sistem slike
 
I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad
 
060516_UMH_AC
060516_UMH_AC060516_UMH_AC
060516_UMH_AC
 
Gist Croft, "Self-organization of the in vitro attached human embryo and its ...
Gist Croft, "Self-organization of the in vitro attached human embryo and its ...Gist Croft, "Self-organization of the in vitro attached human embryo and its ...
Gist Croft, "Self-organization of the in vitro attached human embryo and its ...
 
George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...
George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...
George Church and John Aach, "Stem Cells, Engineered Tissues, and Synthetic E...
 
CRISPR/Cas9 Platform
CRISPR/Cas9 PlatformCRISPR/Cas9 Platform
CRISPR/Cas9 Platform
 
C. trachoamtis detection and genotypings assay
C. trachoamtis detection and genotypings assayC. trachoamtis detection and genotypings assay
C. trachoamtis detection and genotypings assay
 
Dipesh
DipeshDipesh
Dipesh
 
Avances en genética. Utilidad de la NGS y la bioinformática.
Avances en genética. Utilidad de la NGS y la bioinformática.Avances en genética. Utilidad de la NGS y la bioinformática.
Avances en genética. Utilidad de la NGS y la bioinformática.
 
C dna and genomic libraries amirtham
C dna and genomic libraries   amirthamC dna and genomic libraries   amirtham
C dna and genomic libraries amirtham
 
PAG-2004-Roe
PAG-2004-RoePAG-2004-Roe
PAG-2004-Roe
 
Resume Jean Wei 111616
Resume Jean Wei 111616Resume Jean Wei 111616
Resume Jean Wei 111616
 
Single cell.platforms.v1.1
Single cell.platforms.v1.1Single cell.platforms.v1.1
Single cell.platforms.v1.1
 
Long read sequencing - WEHI bioinformatics seminar - tue 16 june 2015
Long read sequencing -  WEHI  bioinformatics seminar - tue 16 june 2015Long read sequencing -  WEHI  bioinformatics seminar - tue 16 june 2015
Long read sequencing - WEHI bioinformatics seminar - tue 16 june 2015
 
Molecular biology
Molecular biologyMolecular biology
Molecular biology
 
J. Clin. Microbiol.-2015-Liljander-2810-5
J. Clin. Microbiol.-2015-Liljander-2810-5J. Clin. Microbiol.-2015-Liljander-2810-5
J. Clin. Microbiol.-2015-Liljander-2810-5
 
Mackey Bio Perl Bosc2008
Mackey Bio Perl Bosc2008Mackey Bio Perl Bosc2008
Mackey Bio Perl Bosc2008
 
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...
20150918 E. Pompilii - Microarray in diagnosi prenatale: la complessità della...
 

Similar to 126 micro array study for gene expression

126 micro array study for gene expression
126 micro array study for gene expression126 micro array study for gene expression
126 micro array study for gene expression
SHAPE Society
 
132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques
SHAPE Society
 
A comprehensive study of microarray
A comprehensive study of microarrayA comprehensive study of microarray
A comprehensive study of microarray
PRABAL SINGH
 
Marcadores.ppt
Marcadores.pptMarcadores.ppt
Marcadores.ppt
ssuser1163f7
 
Lab2_3_Lecture_DNA_PCR (3).pptx
Lab2_3_Lecture_DNA_PCR (3).pptxLab2_3_Lecture_DNA_PCR (3).pptx
Lab2_3_Lecture_DNA_PCR (3).pptx
karlos64
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
ashharnomani
 
Applications of microarray
Applications of microarrayApplications of microarray
Applications of microarray
prateek kumar
 
cloning and sub-cloning
cloning and sub-cloningcloning and sub-cloning
cloning and sub-cloning
Sandhya Talla
 
2 recombinant dna technology
2 recombinant dna technology2 recombinant dna technology
2 recombinant dna technology
prasanthi rao
 
poster
posterposter
poster
Debjit Ray
 
DNA Microarray notes.pdf
DNA Microarray notes.pdfDNA Microarray notes.pdf
DNA Microarray notes.pdf
RajendraChavhan3
 
DNA Microarray notes.pdf
DNA Microarray notes.pdfDNA Microarray notes.pdf
DNA Microarray notes.pdf
RajendraChavhan3
 
MICROARRAY
MICROARRAYMICROARRAY
MICROARRAY
Sanjay Sinhmar
 
Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip
KAUSHAL SAHU
 
Introduction to Apollo for i5k
Introduction to Apollo for i5kIntroduction to Apollo for i5k
Introduction to Apollo for i5k
Monica Munoz-Torres
 
Recombinant DNA Technology
Recombinant DNA TechnologyRecombinant DNA Technology
Recombinant DNA Technology
Faisal Hussain
 
Cloning dna f inal
Cloning dna f inalCloning dna f inal
Cloning dna f inal
pharmacologyseminars
 
DNA Microarray introdution and application
DNA Microarray introdution and applicationDNA Microarray introdution and application
DNA Microarray introdution and application
Neeraj Sharma
 
Gene Libraries
Gene LibrariesGene Libraries
Gene Libraries
agrawalfalguni43
 
Biotechnology Ap
Biotechnology ApBiotechnology Ap
Biotechnology Ap
smithbio
 

Similar to 126 micro array study for gene expression (20)

126 micro array study for gene expression
126 micro array study for gene expression126 micro array study for gene expression
126 micro array study for gene expression
 
132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques
 
A comprehensive study of microarray
A comprehensive study of microarrayA comprehensive study of microarray
A comprehensive study of microarray
 
Marcadores.ppt
Marcadores.pptMarcadores.ppt
Marcadores.ppt
 
Lab2_3_Lecture_DNA_PCR (3).pptx
Lab2_3_Lecture_DNA_PCR (3).pptxLab2_3_Lecture_DNA_PCR (3).pptx
Lab2_3_Lecture_DNA_PCR (3).pptx
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
 
Applications of microarray
Applications of microarrayApplications of microarray
Applications of microarray
 
cloning and sub-cloning
cloning and sub-cloningcloning and sub-cloning
cloning and sub-cloning
 
2 recombinant dna technology
2 recombinant dna technology2 recombinant dna technology
2 recombinant dna technology
 
poster
posterposter
poster
 
DNA Microarray notes.pdf
DNA Microarray notes.pdfDNA Microarray notes.pdf
DNA Microarray notes.pdf
 
DNA Microarray notes.pdf
DNA Microarray notes.pdfDNA Microarray notes.pdf
DNA Microarray notes.pdf
 
MICROARRAY
MICROARRAYMICROARRAY
MICROARRAY
 
Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip Microarray technology, biochip, DNA chip
Microarray technology, biochip, DNA chip
 
Introduction to Apollo for i5k
Introduction to Apollo for i5kIntroduction to Apollo for i5k
Introduction to Apollo for i5k
 
Recombinant DNA Technology
Recombinant DNA TechnologyRecombinant DNA Technology
Recombinant DNA Technology
 
Cloning dna f inal
Cloning dna f inalCloning dna f inal
Cloning dna f inal
 
DNA Microarray introdution and application
DNA Microarray introdution and applicationDNA Microarray introdution and application
DNA Microarray introdution and application
 
Gene Libraries
Gene LibrariesGene Libraries
Gene Libraries
 
Biotechnology Ap
Biotechnology ApBiotechnology Ap
Biotechnology Ap
 

More from Society for Heart Attack Prevention and Eradication

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Society for Heart Attack Prevention and Eradication
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
Society for Heart Attack Prevention and Eradication
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
Society for Heart Attack Prevention and Eradication
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
Society for Heart Attack Prevention and Eradication
 
Vp watch2002
Vp watch2002Vp watch2002
Vp symposium31602
Vp symposium31602Vp symposium31602
Vpschoenhagen
VpschoenhagenVpschoenhagen

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

126 micro array study for gene expression

  • 1. 09/08/16 1 Micro-array study for gene expression
  • 2. 09/08/16 2 History cDNA microarrays have evolved from Southern blots, withcDNA microarrays have evolved from Southern blots, with clone libraries gridded out on nylon membrane filtersclone libraries gridded out on nylon membrane filters being an important and still widely used intermediate.being an important and still widely used intermediate. Things took off with the introduction of non-porous solidThings took off with the introduction of non-porous solid supports, such as glass - these permitted miniaturization -supports, such as glass - these permitted miniaturization - and fluorescence based detection. Currently, about 20,000and fluorescence based detection. Currently, about 20,000 cDNAs can be spotted onto a microscope slide.cDNAs can be spotted onto a microscope slide.
  • 3. 09/08/16 3 Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, THE PROCESSTHE PROCESS Building the Chip: MASSIVE PCR PCR PURIFICATION and PREPARATION PREPARING SLIDES PRINTING Preparing RNA: CELL CULTURE AND HARVEST RNA ISOLATION cDNA PRODUCTION Hybing the Chip: POST PROCESSING ARRAY HYBRIDIZATION PROBE LABELING DATA ANALYSIS
  • 4. 09/08/16 4Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, cDNA clones (probes) PCR product amplification purification printing microarray Hybridise target to microarray mRNA target) excitation laser 1laser 2 emission scanning analysis overlay images and normalise 0.1nl/spot
  • 5. 09/08/16 5Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Preparing RNA: RNA ISOLATION cDNA PRODUCTION Designing experiments to profile conditions/perturbations/ mutations and carefully controlled growth conditions RNA yield and purity are determined by system. PolyA isolation is preferable but total RNA is useable. Two RNA samples are hybridized/chip. Single strand synthesis or amplification of RNA can be performed. cDNA production includes incorporation of Aminoallyl-dUTP. Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Preparing RNA: RNA ISOLATION cDNA PRODUCTION Designing experiments to profile conditions/perturbations/ mutations and carefully controlled growth conditions RNA yield and purity are determined by system. PolyA isolation is preferable but total RNA is useable. Two RNA samples are hybridized/chip. Single strand synthesis or amplification of RNA can be performed. cDNA production includes incorporation of Aminoallyl-dUTP. Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Preparing RNA: RNA ISOLATION cDNA PRODUCTION Designing experiments to obtain conditions necessary to induce changes in the plaque to cause its rupture RNA yield and purity are determined by system. Single strand synthesis or amplification of RNA can be performed. OBTAINING THE TARGET TISSUE
  • 6. 09/08/16 6Department of Statistics, University of California, Berkeley, and Hybing the Chip: ARRAY HYBRIDIZATION PROBE LABELING DATA ANALYSIS Cy3 and Cy5 RNA samples are simultaneously hybridized to chip. Hybs are performed for 5-12 hours and then chips are washed. Two RNA samples are labelled with Cy3 or Cy5 monofunctional dyes via a chemical coupling to AA-dUTP. Samples are purified using a PCR cleanup kit. Ratio measurements are determined via quantification of 532 nm and 635 nm emission values. Data are uploaded to the appropriate database where statistical and other analyses can then be performed.
  • 7. 09/08/16 7Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, Biological Question Sample preparationMicroarray Life Cycle Data Analysis & Modeling Microarray Reaction Microarray Detection aken from Schena & Davis
  • 8. 09/08/16 8 Schematic of probe preparation , hybridization, scanning and immage analysis
  • 10. 09/08/16 10 Our Aim • We intend to induce rupture of atherosclerotic plaque in apo-e mice by injecting several drugs, which we hope will cause rupture of the plaque by altering the hemodynamic system and raising the oxidative stress and alter the composition of the plaque. • After achieving this goal we will perform gene- array study on these specimens and will try to find out which genes are expressed more in plaques which are ruptured or are prone to rupture, by comparing our results at the histopathology lab which will define the structural details of such vulnerable plaques.
  • 11. 09/08/16 11 DNA Sequence Synthesis  We are going to design a genearray slide based onWe are going to design a genearray slide based on oligonucleotide sequences that we will deriveoligonucleotide sequences that we will derive from the genes that we are interested in.from the genes that we are interested in.  To do this, we will proceed as follows:To do this, we will proceed as follows:  First we will gather the cDNA or mRNAFirst we will gather the cDNA or mRNA sequences of the desired genes from Entrez.sequences of the desired genes from Entrez.  Then we will pickup a sequence of genes from thatThen we will pickup a sequence of genes from that particular gene and by using Primer Premierparticular gene and by using Primer Premier program we will design a primer to use as aprogram we will design a primer to use as a hybridization probe.hybridization probe.
  • 12. 09/08/16 12Department of Statistics, University of California, Berkeley, and Division of Genetics and Bioinformatics, The Walter and Eliza Hall Institute of Medical Research,
  • 15. 09/08/16 15  We will order a probe to be made by a company that willWe will order a probe to be made by a company that will make that on a commercial basis.make that on a commercial basis.  The micro array-chip, we will make at the lab byThe micro array-chip, we will make at the lab by synthesizing cDNA from mRNA, that we isolated.synthesizing cDNA from mRNA, that we isolated.  We will obtain the tissue samples from the mice, accordingWe will obtain the tissue samples from the mice, according to our study design, we will purify the mRNA accordingto our study design, we will purify the mRNA according the specific protocol.the specific protocol.  mRNA from the target will be converted into cDNA, andmRNA from the target will be converted into cDNA, and allowed to hybridiz on the microarray chip that weallowed to hybridiz on the microarray chip that we designeddesigned  The emission of colors will be captured by the scanner,The emission of colors will be captured by the scanner, and the results will be analysed depending upon theirand the results will be analysed depending upon their intensity and presence and absence of colorintensity and presence and absence of color
  • 16. 09/08/16 16 • Drugs being used to induce rupture of atherosclerotic plaque in apo-e mice
  • 17. 09/08/16 17 Drugs being used • LNAME • Adrenalin • Cocaine • Xanthine • Xanthine Oxidase • Interleukin-1 beta • Methionine • Buthionine Sulfoximine
  • 18. 09/08/16 18 If we do not find anything Very pleasant, at least we shalll find something new